Chen et al., 2020 - Google Patents

Woolly monkey–HBV infection in squirrel monkeys as a surrogate nonhuman primate model of HBV infection

Chen et al., 2020

View PDF @Full View
Document ID
3268947908217791155
Author
Chen C
Winer B
Chavez D
Guerra B
Brasky K
Eng S
Salas E
Tam D
Simmons J
Abee C
Delaney W
Ploss A
Lanford R
Voitenleitner C
Publication year
Publication venue
Hepatology communications

External Links

Snippet

Development of curative therapies for chronic hepatitis B virus (HBV) infection will likely require new animal models. Here, we evaluate HBV infection in squirrel monkeys based on the high‐sequence homology of the HBV receptor, Na+/taurocholate co‐transporting …
Continue reading at aasldpubs.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse Transcribing DNA Viruses
    • C12N2730/00011—Reverse Transcribing DNA Viruses
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense
    • C12N2770/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense ssRNA Viruses positive-sense

Similar Documents

Publication Publication Date Title
Allweiss et al. Experimental in vitro and in vivo models for the study of human hepatitis B virus infection
Lempp et al. Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes
Guo et al. HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways
Ye et al. Adeno-associated virus vector mediated delivery of the HBV genome induces chronic hepatitis B virus infection and liver fibrosis in mice
Chen et al. Immune tolerance split between hepatitis B virus precore and core proteins
US20170327797A1 (en) Recombinant hbv cccdna, the method to generate thereof and the use thereof
Li et al. Cell culture models and animal models for HBV study
Dandri et al. Mouse models of hepatitis B and delta virus infection
Suárez-Amarán et al. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction
Thi et al. ARB-1740, a RNA interference therapeutic for chronic hepatitis B infection
Chen et al. Woolly monkey–HBV infection in squirrel monkeys as a surrogate nonhuman primate model of HBV infection
Dandri et al. Animal models of HBV infection
He et al. Modification of three amino acids in sodium taurocholate cotransporting polypeptide renders mice susceptible to infection with hepatitis D virus in vivo
Liu et al. Animal models of hepatitis B virus infection–success, challenges, and future directions
Ortega-Prieto et al. In vivo model systems for hepatitis B virus research
Dandri et al. Experimental models and therapeutic approaches for HBV
Winer et al. Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection
JP2008022853A (en) Chimeric animal model susceptible to human hepatitis c virus infection
Ploss et al. Animal models of hepatitis C virus infection
Winer et al. In vivo models of hepatitis B and C virus infection
Hirai-Yuki et al. Murine models of hepatitis A virus infection
Burwitz et al. Animal models for the study of human hepatitis B and D virus infection: new insights and progress
Chen et al. New insights into hepatitis B virus biology and implications for novel antiviral strategies
Dandri et al. Small animal model systems for studying hepatitis B virus replication and pathogenesis
Wu et al. A novel recombinant cccDNA-based mouse model with long term maintenance of rcccDNA and antigenemia